On September 13, 2022 Yosef Keret, a non-executive director on the Board of Directors of Mawson Infrastructure Group Inc., informed the Company of his decision to retire from the Board effective as at September 14, 2022. Mr. Keret has been a valued member of the Board since 2017, when the Company was known as Wize Pharma, Inc, was a biotechnology company, and was headquartered in Israel. Mr. Keret remained a member of the Board after March 9, 2021, as previously reported in the Schedule 14(f) filed on February 26, 2021 and the Current Report on Form 8-K filed on March 9, 2021, when, pursuant to a Bid Agreement dated December 30, 2020, a change of control of Wize occurred and the other directors of Wize resigned.

Mr. Keret agreed to remain a member of the Board of the Company to assist with a smooth transition from the Wize business to the Company's current business as a Bitcoin miner. Mr. Keret remaining as a director provided continuity on the Board during that time. That period of transition is largely complete, and Mr. Keret considers that it is an appropriate time for him to resign from the Board of the Company and to focus his attention on his other business commitments and obligations.